Stonepine Capital Management as of March 31, 2023
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 22 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Plc - Spnr Sponsored Ads | 30.7 | $92M | 6.3M | 14.58 | |
| Galapagos Nv- Spon Adr (GLPG) | 10.1 | $30M | 782k | 38.64 | |
| Cti Biopharma | 9.2 | $27M | 6.5M | 4.20 | |
| Adma Biologics (ADMA) | 8.5 | $25M | 7.7M | 3.31 | |
| Quidel Corp (QDEL) | 8.3 | $25M | 279k | 89.09 | |
| Xeris Pharmaceuticals (XERS) | 4.7 | $14M | 8.6M | 1.63 | |
| Maxcyte (MXCT) | 4.5 | $13M | 2.7M | 4.95 | |
| Third Harmonic Bio (THRD) | 4.3 | $13M | 3.1M | 4.12 | |
| Atyr Pharma Com New (LIFE) | 3.4 | $10M | 4.8M | 2.10 | |
| Xoma Corp Com New (XOMA) | 2.3 | $6.7M | 318k | 21.11 | |
| Castle Biosciences (CSTL) | 2.2 | $6.7M | 293k | 22.72 | |
| Urogen Pharma (URGN) | 2.2 | $6.5M | 702k | 9.24 | |
| Rezolute Com New (RZLT) | 2.0 | $5.9M | 3.1M | 1.92 | |
| Evolus (EOLS) | 1.6 | $4.9M | 579k | 8.46 | |
| Dynavax Technologies Corp Com New (DVAX) | 1.4 | $4.1M | 417k | 9.81 | |
| Apollo Endosurgery | 1.2 | $3.7M | 370k | 9.92 | |
| Travere Therapeutics Note 2.500% 9/1 (TVTX) | 1.0 | $3.0M | 132k | 22.49 | |
| Exagen (XGN) | 0.8 | $2.5M | 1.0M | 2.43 | |
| Atea Pharmaceuticals (AVIR) | 0.8 | $2.3M | 685k | 3.35 | |
| Scynexis Com New (SCYX) | 0.5 | $1.4M | 450k | 3.00 | |
| Conformis Com New | 0.2 | $648k | 403k | 1.61 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $1.3k | 1.0k | 1.27 |
